We report a long-term follow-up of a female patient with a multifocal extremity desmoid tumour. She had 3 local recurrences after excision and developed a second unresectable pelvic tumour that has remained unchanged in size for 14 years since starting tamoxifen treatment.
RockMGPritchardDJReimanHMSouleEHBrewsterRC. Extra-abdominal desmoid tumors. J Bone Joint Surg Am1984;66:1369–74.
4.
LewisJJBolandPJLeungDHWoodruffJMBrennanMF. The enigma of desmoid tumors. Ann Surg1999;229:866–73.
5.
DalenBPBerghPMGunterbergBU. Desmoid tumors: A clinical review of 30 patients with more than 20 years' follow-up. Acta Orthop Scand2003;74:455–9.
6.
EasterDWHalaszNA. Recent trends in the management of desmoid tumors. Summary of 19 cases and review of the literature. Ann Surg1989;210:765–9.
7.
PritchardDJNascimentoAGPetersenIA. Local control of extra-abdominal desmoid tumors. J Bone Joint Surg Am1996;78:848–54.
8.
MerchantNBLewisJJWoodruffJMLeungDHBrennanMF. Extremity and trunk desmoid tumours: A multifactorial analysis of outcome. Cancer1999;86:2045–52.
9.
PignattiGBarbanti-BrodanoGFerrariDGherlinzoniFBertoniFBacchiniP. Extraabdominal desmoid tumor. A study of 83 cases. Clin Orthop2000;375:207–13.
10.
SorensenAKellerJNielsenOSJensenOM. Treatment of aggressive fibromatosis: A retrospective study of 72 patients followed for 1–27 years. Acta Orthop Scand2002;73:213–9.
11.
GronchiACasaliPGMarianiLLo VulloSColecchiaMLozzaL. Quality of surgery and outcome in extra-abdominal aggressive fibromatosis: A series of patients surgically treated at a single institution. J Clin Oncol2003;21:1390–7.
12.
BalloMTZagarsGKPollackAPistersPWPollockRA. Desmoid tumor: Prognostic factors and outcome after surgery, radiation therapy, or combined surgery and radiation therapy. J Clin Oncol1999;17:158–67.
13.
NuyttensJJRustPFThomasCRJrTurrisiAT3rd. Surgery versus radiation therapy for patients with aggressive fibromatosis or desmoid tumors: A comparative review of 22 articles. Cancer2000;88:1517–23.
14.
BaliskiCRTempleWJArthurKSchacharNS. Desmoid tumors: A novel approach for local control. J Surg Oncol2002;80:96–9.
15.
SerpellJWPaddle-LedinekJEJohnsonWR. Modification of growth of desmoid tumours in tissue culture by anti-oestrogenic substances: A preliminary report. Aust N Z J Surg1996;66:457–63.
16.
KinzbrunnerBRitterSDomingoJRosenthalCJ. Remission of rapidly growing desmoid tumours after tamoxifen therapy. Cancer1983;52:2201–4.
17.
ThomasSDatta-GuptaSKapurBM. Treatment of recurrent desmoid tumour with tamoxifen. Aust N Z J Surg1990;60:919–21.
18.
ProcterHSinghLBaumMBrinkleyD. Response of multicentric desmoid tumours to tamoxifen. Br J Surg1987;74:401.
19.
WilckenNTattersallMH. Endocrine therapy for desmoid tumors. Cancer1991;68:1384–8.
20.
PosnerMCShiuMHNewsomeJLHajduSIGaynorJJBrennanMF. The desmoid tumor. Arch Surg1989;124:191–6.
21.
LimCLWalkerMJMehtaRRDas GuptaTK. Estrogen and antiestrogen binding sites in desmoid tumors. Eur J Cancer Clin Oncol1986;22:583–7.
22.
CollettaAAWakefieldLMHowellFVvan RoozendaalKEDanielpourDEbbsSR. Anti-oestrogens induce the secretion of active transforming growth factor beta from human fetal fibroblasts. Br J Cancer1990;62:405–9.
